首页> 外文OA文献 >Pharmacokinetically-targeted BU and fludarabine as conditioning before allogeneic hematopoietic cell transplantation for adults with ALL in first remission

【2h】

Pharmacokinetically-targeted BU and fludarabine as conditioning before allogeneic hematopoietic cell transplantation for adults with ALL in first remission

机译：药代履靶向的BU和FLUDARABINE作为在第一次缓解中的同种异体造血细胞移植前的调理

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
G Kunter; J B Perkins; J Pidala; T Nishihori; M A Kharfan-Dabaja; T Field; H Fernandez; L Perez; F Locke; E Ayala; M Tomblyn; J L Ochoa-Bayona; B Betts; M Nieder; C Anasetti;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种
中图分类
入库时间 2022-08-20 22:19:16

相似文献

外文文献
中文文献
专利

1. Pharmacokinetically-targeted BU and fludarabine as conditioning before allogeneic hematopoietic cell transplantation for adults with ALL in first remission [J] . KunterG., PerkinsJ.B., PidalaJ., Bone marrow transplantation . 2014,第1期

机译：成人首次缓解的同种异体造血细胞移植前以药代动力学靶向的BU和氟达拉滨为条件
2. More Intensive Fludarabine/Busulfan (Flu/Bu) Conditioning Regimens Result in Similar Outcomes Without Adding Serious Toxicity When Compared to Fludarabine/Melphalan (Flu/Mel) in Patients Undergoing Allogeneic Hematopoietic Cell Transplant (Allo-HCT) [J] . Jeremy Pappacena, Valkal Bhatt, Gunjan L. Shah, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2018,第3期

机译：更加强烈的氟纳比林/母艇（Flu / Bu）调理方案导致类似的结果，而不是在接受同种异体造血细胞移植（Allo-Hct）的血糖胺/ Melphalan（Flu / Mel）时添加严重毒性
3. More Intensive Fludarabine/Busulfan (Flu/Bu) Conditioning Regimens Result in Similar Outcomes Without Adding Serious Toxicity When Compared to Fludarabine/Melphalan (Flu/Mel) in Patients Undergoing Allogeneic Hematopoietic Cell Transplant (Allo-HCT) [J] . Jeremy Pappacena, Valkal Bhatt, Gunjan L. Shah, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2018,第3期

机译：更加强烈的氟纳比林/母艇（Flu / Bu）调理方案导致类似的结果，而不是在接受同种异体造血细胞移植（Allo-Hct）的血糖胺/ Melphalan（Flu / Mel）时添加严重毒性
4. THE EFFECT OF INHIBITORY KILLER-CELL IG-LIKE RECEPTOR (IKIR) MATCHING IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (HCT) [C] . David Senitzer, Joel Y. Sun, Arisa Oki, Clinical Histocompatibility Workshop. . 2009

机译：同种异体造血细胞移植（HCT）中抑制杀伤细胞IG样受体（IKIR）匹配的影响
5. Pre-Transplant Risk Factors Associated With Worse Outcomes in Adolescents and Young Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation [D] . Friend, Brian. 2018

机译：与经历同种异体造血干细胞移植的青少年和青少年较差的预移植危险因素
6. Busulfan plus fludarabine as a myeloablative conditioning regimen compared with busulfan plus cyclophosphamide for acute myeloid leukemia in first complete remission undergoing allogeneic hematopoietic stem cell transplantation: a prospective and multicenter study [O] . Hui Liu, Xiao Zhai, Zhaoyang Song, 2013

机译：与白消安加环磷酰胺相比白消安加氟达拉滨是一种急性清髓治疗方案用于同种异体造血干细胞移植首次完全缓解的急性髓细胞性白血病：一项前瞻性和多中心研究
7. More Intensive Fludarabine/Busulfan (Flu/Bu) Conditioning Regimens Result in Similar Outcomes Without Adding Serious Toxicity When Compared to Fludarabine/Melphalan (Flu/Mel) in Patients Undergoing Allogeneic Hematopoietic Cell Transplant (Allo-HCT) [O] . Jeremy Pappacena, Valkal Bhatt, Gunjan L. Shah, 2018

机译：更加强烈的氟纳比林/母艇（Flu / Bu）调理方案导致类似的结果，而不是在接受同种异体造血细胞移植（Allo-Hct）的血糖胺/ Melphalan（Flu / Mel）时添加严重毒性

Pharmacokinetically-targeted BU and fludarabine as conditioning before allogeneic hematopoietic cell transplantation for adults with ALL in first remission

著录项

相似文献

相关主题

期刊订阅